Centro Hospitalar e Universitário de Coimbra (CHUC)

Hospital


Location: Coimbra, Portugal (PT) PT

ISNI: 0000000106861985

ROR: https://ror.org/04032fz76

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices (2021) Herman A, Uter W, Rustemeyer T, Matura M, Aalto-Korte K, Duus Johansen J, Goncalo M, et al. Journal article A generic curriculum development model for the biomedical physics component of the educational and training programmes of the non-physics healthcare professions (2021) Caruana CJ, Karenauskaite V, Mornstein V, Vano E, Pace E, Lammertsma AA, Maas AJ, et al. Journal article Brain fMRI Predicts Responses to Certolizumab Pegol in RA. an International, Multi-center, Randomized, Double-blind, Placebocontrolled Trial (PreCePRA) (2020) Rech J, Schenker H, Tascilar K, Hagen M, Kleyer A, Simon D, Mendez LV, et al. Conference contribution CENTRAL NERVOUS SYSTEM PAIN RESPONSE AND COMPONENTS OF DISEASE ACTIVITY IN RA PATIENTS AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO: A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) Schenker H, Rech J, Tascilar K, Hagen M, Schoenau V, Sergeeva M, Selvakumar M, et al. Conference contribution PREDICTION OF RESPONSE TO CERTOLIZUMAB PEGOL TREATMENT BY FUNCTIONAL MRI OF THE BRAIN: AN INTERNATIONAL, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (PRECEPRA) (2020) Rech J, Tascilar K, Schenker H, Sergeeva M, Selvakumar M, Konerth L, Prade J, et al. Conference contribution LONGITUDINAL CHANGE IN THE CENTRAL NERVOUS SYSTEM PAIN RESPONSE AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO. A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) Rech J, Tascilar K, Schenker H, Hagen M, Sergeeva M, Selvakumar M, Konerth L, et al. Conference contribution Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence (2020) Maurer M, Aberer W, Agondi R, Al-Ahmad M, Al-Nesf MA, Ansotegui I, Arnaout R, et al. Journal article Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course (2019) Cavagna L, Trallero-Araguas E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, et al. Journal article RELATIONSHIP BETWEEN ANTI-MDA5 ANTIBODIES AND CANCER: RETROSPECTIVE ANALYSIS OF AN INTERNATIONAL AND MULTIDISCIPLINARY COHORT (2019) De Stefano L, Castaneda S, De Langhe E, Distler J, Knitza J, Cavazzana I, Meyer A, et al. Conference contribution Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease (2019) Baldeiras I, Santana I, Leitao MJ, Vieira D, Duro D, Mroczko B, Kornhuber J, Lewczuk P Journal article
1 2 3